Wanbury informs about award of order

12 Mar 2026 Evaluate

Pursuant to Regulation 30 (6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, Wanbury (WL) has informed the following: 1. Sertraline Form II approval received from ANVISA, BRAZIL. This is in addition to Sertraline hydrochloride Form 1 approval that Wanbury already has. WL currently hold 75% market share for sertraline in Brazil's market. Approval for Form II, will help in further consolidation company's share of business. 2. WL has received approval from one of the largest customers for a special grade of metformin. DC grade with potential business opportunity to be estimated around Rupees 15 crore per annum. Both the API manufacturing sites i.e. Patalganga and Tanuku of WL are continued to be compliant as per cGMP Rules and Regulations.

The above information is a part of company’s filings submitted to BSE.


Wanbury Share Price

247.25 -2.05 (-0.82%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×